5,000 Shares in Doximity, Inc. $DOCS Bought by Corient IA LLC

Key Points

• Corient IA LLC acquired 5,000 shares of Doximity, Inc. valued at approximately $290,000 during the first quarter, indicating growing institutional interest in the company.
• Doximity's quarterly earnings report showed an EPS of $0.36, surpassing analysts' expectations and reflecting a 15.2% year-over-year revenue increase.
• Institutional investors and hedge funds now own 87.19% of Doximity's stock, highlighting significant institutional backing for the company.

Corient IA LLC bought a new stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 5,000 shares of the company's stock, valued at approximately $290,000.

Several other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. increased its holdings in shares of Doximity by 8.8% during the 1st quarter. Vanguard Group Inc. now owns 12,194,492 shares of the company's stock valued at $707,646,000 after purchasing an additional 990,923 shares in the last quarter. Invesco Ltd. increased its holdings in Doximity by 54.8% in the 1st quarter. Invesco Ltd. now owns 1,969,326 shares of the company's stock worth $114,280,000 after acquiring an additional 696,923 shares in the last quarter. Fuller & Thaler Asset Management Inc. increased its holdings in Doximity by 8.5% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 1,579,708 shares of the company's stock worth $84,341,000 after acquiring an additional 124,216 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in Doximity by 4.2% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,576,455 shares of the company's stock worth $84,167,000 after acquiring an additional 63,815 shares in the last quarter. Finally, Northern Trust Corp increased its holdings in Doximity by 9.4% in the 4th quarter. Northern Trust Corp now owns 1,459,185 shares of the company's stock worth $77,906,000 after acquiring an additional 125,332 shares in the last quarter. 87.19% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several brokerages recently commented on DOCS. Needham & Company LLC boosted their price target on shares of Doximity from $67.00 to $75.00 and gave the stock a "buy" rating in a report on Friday, August 8th. KeyCorp boosted their price target on shares of Doximity from $65.00 to $70.00 and gave the stock an "overweight" rating in a report on Monday, July 14th. Piper Sandler lifted their target price on shares of Doximity from $65.00 to $69.00 and gave the stock an "overweight" rating in a research note on Monday, August 11th. Evercore ISI raised shares of Doximity from an "in-line" rating to an "outperform" rating and lifted their target price for the stock from $50.00 to $70.00 in a research note on Wednesday, July 9th. Finally, The Goldman Sachs Group set a $50.00 target price on shares of Doximity and gave the stock a "neutral" rating in a research note on Wednesday, May 21st. Two equities research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and ten have given a Hold rating to the stock. Based on data from MarketBeat, Doximity currently has a consensus rating of "Moderate Buy" and an average target price of $66.21.

Insiders Place Their Bets

In other Doximity news, Director Timothy S. Cabral sold 10,000 shares of the business's stock in a transaction dated Wednesday, June 25th. The shares were sold at an average price of $60.00, for a total transaction of $600,000.00. Following the sale, the director directly owned 6,360 shares in the company, valued at $381,600. This represents a 61.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Kira Scherer Wampler sold 2,000 shares of the business's stock in a transaction dated Friday, August 1st. The stock was sold at an average price of $57.09, for a total transaction of $114,180.00. Following the sale, the director owned 16,618 shares in the company, valued at $948,721.62. This trade represents a 10.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 36,000 shares of company stock worth $2,140,940 over the last three months. Company insiders own 31.30% of the company's stock.

Doximity Stock Performance

Shares of DOCS stock traded up $0.7980 on Wednesday, hitting $64.4080. 1,931,944 shares of the stock traded hands, compared to its average volume of 2,336,196. The firm's 50-day moving average price is $60.42 and its two-hundred day moving average price is $60.37. The stock has a market capitalization of $12.06 billion, a PE ratio of 64.41, a PEG ratio of 4.10 and a beta of 1.36. Doximity, Inc. has a twelve month low of $35.32 and a twelve month high of $85.21.

Doximity (NASDAQ:DOCS - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. The business's quarterly revenue was up 15.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.28 EPS. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. On average, equities research analysts anticipate that Doximity, Inc. will post 0.99 EPS for the current fiscal year.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.